SmartLabs’ Post

Unleash the Potential of Accelerate by BHG™ for Clinical Development! Embrace the future of drug and device development with state-of-the-art tools and solutions. The clinical development process from end to end is complex and interdependent. 💡 Leverage Accelerate by BHG™! Our comprehensive and exclusive diagnostic tool and strategic management system. With a vast array of over 135 measures, it facilitates integrated planning throughout the entire clinical development lifecycle. This valuable resource empowers Biopharmaceutical companies to proactively recognize obstacles, prioritize tasks, offer effective solutions, and maximize achievements. 🌐 www.bioshealthgroup.com #Biotech #LifeSciences #HealthcareInnovation #Pharma #Biomedical #Genomics #DrugDiscovery #Biotechnology #HealthTech #clinicaldevelopment #clinicalresearch #patientfocused

How does prioritizing a quality end product from the outset contribute to effectively managing the journey to commercialization with quality raw materials? Join Randall A. & others for a roundtable discussion on the topic at our Advanced Therapies Roundtable Xchange happening in San Diego, February 29th 2024. To view all facilitators, agendas, registration info and more, please visit: https://lnkd.in/dcuUeiVC Note: Registration is only open to Senior Scientists and above actively working in the pharmaceutical/biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #drugdiscovery #biotech #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #clinicaldevelopment #clinicalstudies #clinicaltrials #biomarkers #oncology #genomics #pharmaceutical #advancedtherapies #manufacturing #therapeutics #therapies #oligonucleotide #genetherapies

How does prioritizing a quality end product from the outset contribute to effectively managing the journey to commercialization with quality raw materials? Join Randall A. & others for a roundtable discussion on the topic at our Advanced Therapies Roundtable Xchange happening in San Diego, February 29th 2024. To view all facilitators, agendas, registration info and more, please visit: https://lnkd.in/exrsm4AC Note: Registration is only open to Senior Scientists and above actively working in the pharmaceutical/biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #drugdiscovery #biotech #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #clinicaldevelopment #clinicalstudies #clinicaltrials #biomarkers #oncology #genomics #pharmaceutical #advancedtherapies #manufacturing #therapeutics #therapies #oligonucleotide #genetherapies

Read the full post: https://bit.ly/49NKaiX Rare diseases account for 30% of the product pipeline. Natalia Mühlemann discusses: ✅ Endpoint construction; ✅ Adaptive and seamless #clinicaltrial designs; ✅ #Bayesian approaches; and ✅ Use of natural history studies. #biotech #pharma #pharmaceutical #pharmaceuticalindustry #adaptivetrials #RWD #realworlddata #Phase1 #Phase2 #drug #therapeutics

📰 ✨✔We are thrilled to announce the publication of our latest article 'Oromucosal spray products – Viscosity impact on spray performance evaluation' in the Journal of Drug Delivery Science and Technology. 🔬This research aims to highlight the significance of investigating quality attributes and their impact on spray performance from the initial stages of development. 👩🔬The authors of this research paper are Francisca Bastos Silva, Andreia Tabanez, Maria Aquino, Antonio Lucas Nunes and Sergio Simoes. 👉 Follow the link to see this work: https://lnkd.in/dTjf2qjM  #witheyesetonthefuture #followbluepharma #Bluepharma #Bluepharma23anos #Bluepharmaacelera2030 #pharmaceuticalindustry #pharmaceutical #industry #indústriafarmacêutica #innovation #development #technology #health #pharmaceuticals #generics #CRDMO #CDMO #CMO #complexinjectabels  #highpotentproducts #Pharma #lifescience #oncology #research #pharma

Digital health has been one of the winning strategies to secure the value of drug assets, delivering differentiated treatment experiences, and improving treatment adherence to actual patients. As digital innovations evolve rapidly, we organized a roundtable discussion on how to successfully develop digital health solutions with Jim Parshall, Executive Director – Delivery Device Electronics & Systems Engineering at Eli Lilly, Rachel Sha, former VP of Digital Strategy, Partnering, and Governance at Sanofi, and Brad Van Orden, former Director of Digital Medicine & Digital Therapeutics at Bristol-Myers Squibb. Click here to read the recap including 3 key tips for success: https://lnkd.in/e8XH9Bm2 #Pharmaceutical #DigitalHealth #TreatmentExperience

Accelerating Drug Discovery & Personalized Medicine: Imagine a continuous stream of real-world data on early-stage disease progression. PONS provides this, enabling pharmaceutical companies to develop life-saving treatments faster. It paves the way for personalized medicine, tailoring therapies to individual patient needs. #digitalhealth #biotech #imagingasbiomarker #futureofhealth #drugdiscovery #pharma

Provident Research stand in solidarity with those affected by rare diseases, and in support of those developing the solutions. Today, we express our gratitude to the dedicated clinical research community for their tireless efforts in advancing treatments for rare diseases. #raredisease #rarediseaseday #clinicalresearch #biotech #pharmaceutical #medicaldevices

How does prioritizing a quality end product from the outset contribute to effectively managing the journey to commercialization with quality raw materials? Join Randall A. & others for a roundtable discussion on the topic at our Advanced Therapies Roundtable Xchange happening in San Diego, February 29th 2024. To view all facilitators, agendas, registration info and more, please visit: https://lnkd.in/eQAUQU7Y Note: Registration is only open to Senior Scientists and above actively working in the pharmaceutical/biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #drugdiscovery #biotech #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #clinicaldevelopment #clinicalstudies #clinicaltrials #biomarkers #oncology #genomics #pharmaceutical #advancedtherapies #manufacturing #therapeutics #therapies #oligonucleotide #genetherapies

Shout out to Eli Lilly and Company who secured its position in the top 10 for both innovation and invention, climbing two places on the Innovation Index (4th place) while experiencing a three-place decline on the Invention Index (7th place). Financially, the company saw a significant increase in revenue, accompanied by a nearly 30% boost in R&D spending. Additionally, Jardiance (empagliflozin), one of Lilly's flagship Type 2 diabetes products, garnered new indications for chronic kidney disease and symptomatic chronic heart failure regardless of ejection fraction. The company achieved significant milestones in its pipeline, with positive Phase 3 results for donanemab for Alzheimer’s disease. It also initiated Phase 3 studies for retatrutide, a triple hormone receptor agonist of GLP-1, glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptors (GCGR), and for orforglipron, a non-peptide GLP-1 receptor agonist. Read the full analysis at https://lnkd.in/ei3fjshR #pharmaceutical #innovation #PIII2024